Results 141 to 150 of about 4,883,737 (287)
ABSTRACT Objective To clarify the clinical relevance of dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) abnormalities in amyotrophic lateral sclerosis (ALS), with a prespecified focus on sex‐stratified associations with disease progression and short‐term prognosis.
Tomoya Kawazoe +7 more
wiley +1 more source
Predictive biomarkers and preventive strategies for PTLD: a turning point in viro-immunologic precision medicine? [PDF]
Caillard S +4 more
europepmc +1 more source
From Symptomatic Treatment to Disease Modification: A Turning Point in Alzheimer's Disease Management. [PDF]
Sheikh M +4 more
europepmc +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit +11 more
wiley +1 more source
A turning point for youth HIV care in the United States: tailored strategies for adolescents and young adults. [PDF]
Martinez O +16 more
europepmc +1 more source
Reply: Lecanemab: turning point, or status quo? An ethics perspective. [PDF]
Hardy J, Mummery C.
europepmc +1 more source
T1 Over Squared Proton Density Ratio to Characterize Multiple Sclerosis Lesions
ABSTRACT Objective Differentiating remyelinated from demyelinated lesions in MS remains challenging without histological confirmation. This study introduces the T1‐to‐PD2 ratio (TPR) imaging approach and evaluates its ability to characterize MS lesions alongside other quantitative MRI (qMRI) metrics. Methods Thirty individuals with MS (mean age: 47.5 ±
Sarah J. Wright +10 more
wiley +1 more source
Atmospheric oxidation capacity at northern mid-latitude regions is reaching a turning point. [PDF]
Wei L +9 more
europepmc +1 more source

